A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer

Recently, it was reported that ubiquilin 4 (UBQLN4) alteration was associated with genomic instability in some cancers. However, whether UBQLN4 is a valuable biomarker for the prognosis of immunotherapy in pan-cancer was not identified. We evaluated the biologic and oncologic significance of UBQLN4...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Tong, Ye, Wang, Zhi, Liu, Yi, Dai, Xiaobo, Zhu, Yuxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443395/
https://www.ncbi.nlm.nih.gov/pubmed/34539785
http://dx.doi.org/10.1155/2021/7404927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443395/
https://www.ncbi.nlm.nih.gov/pubmed/34539785
http://dx.doi.org/10.1155/2021/7404927

Ejemplares similares